लोड हो रहा है...
Circulating endothelial cells and risk of progression in patients with hepatocellular cancer receiving sorafenib
AIM: We investigated the behavior of circulating endothelial cells (CEC) in patients with hepatocellular carcinoma (HCC) receiving sorafenib, and whether CEC levels were associated with time to progression (TTP). MATERIALS & METHODS: CECs in advanced HCC patients receiving sorafenib were counted...
में बचाया:
| में प्रकाशित: | Hepat Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Future Medicine Ltd
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095409/ https://ncbi.nlm.nih.gov/pubmed/30191052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2016-0011 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|